Palo Alto, CA, United States of America

Kevin Yin

USPTO Granted Patents = 2 


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Kevin Yin in Interleukin Production

Introduction

Kevin Yin is an innovative inventor based in Palo Alto, California, who has made significant contributions to the field of biopharmaceuticals. He holds two patents that focus on the development of cholix-IL-10 fusion proteins and methods for their purification and delivery. His work is paving the way for novel therapeutic solutions in the medical field.

Latest Patents

Kevin Yin's latest patents revolve around the compositions, formulations, and purification processes of interleukin production. His inventions include cholix-IL-10 fusion proteins that result in a distinct biological response when administered to individuals. This response is characterized by changes in certain biomarkers and the co-localization of IL-10 in the lamina propria. Additionally, his patents describe innovative oral formulations of these fusion proteins designed for site-specific release in the small intestines or colon. They also highlight advanced methods for purifying IL-10 delivery constructs, ensuring they remain predominantly in their biologically active dimer form.

Career Highlights

Kevin currently works at Applied Molecular Transport Inc., where he utilizes his expertise in molecular biology and pharmaceuticals to advance research and development in drug delivery systems. His focus on interleukin therapy represents a significant intersection of biotechnology and medicine, aiming to create effective treatments for various diseases.

Collaborations

At Applied Molecular Transport Inc., Kevin collaborates with notable professionals such as Derek Maclean and Randall J. Mrsny. These collaborations contribute to the innovative atmosphere of the company and foster an environment where groundbreaking ideas can flourish.

Conclusion

In summary, Kevin Yin is a prominent inventor whose work on cholix-IL-10 fusion proteins has the potential to transform therapeutic approaches in medicine. With his dual patents and collaboration with talented peers, he continues to make strides in the field of biopharmaceutical innovation, enhancing the prospects for future medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…